Issue: January 2013
January 08, 2013
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Cardiology Today Editorial Board members vote on top 10 stories of 2012
Issue: January 2013
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The following are the Top 10 stories of 2012 in the field of cardiology. These developments and issues were selected and deemed important by members of the Cardiology Today Editorial Board. The editors of Cardiology Today value your opinion. Let us know what you think of the Top 10 list.
- Results of the FREEDOM trial: CABG bested PCI for patients with diabetes and multivessel disease
- The promise of renal denervation for resistant hypertension
- New research into PCSK9 to lower cholesterol and improve CV outcomes
- FDA approval of the first subcutaneous ICD system
- The FAME II data: Benefits and cost effectiveness of fractional flow reserve-guided PCI
- Updates in stem cell therapy for cardiac diseases
- Societies publish third universal definition of MI
- The TAVR story: CMS announced coverage for symptomatic aortic valve stenosis and Sapien valve gained expanded indication
- New guidelines address diagnosis and treatment of stable ischemic heart disease
- Tied: Lorcaserin, phentermine/topiramate approved by FDA for treatment of obesity and Increased focus on new anticoagulants for stroke prevention